SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Spironolactone W/ Hydrochlorothiazide patents expire, and when can generic versions of Spironolactone W/ Hydrochlorothiazide launch?
Spironolactone W/ Hydrochlorothiazide is a drug marketed by Ivax Pharms, Lederle, Parke Davis, Purepac Pharm, Upsher Smith, Usl Pharma, Vangard, and Watson Labs. and is included in nine NDAs.
The generic ingredient in SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE is hydrochlorothiazide; spironolactone. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.
Summary for SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 9 |
Patent Applications: | 31 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Chiang Mai University | Phase 3 |
Medical University of Bialystok | N/A |
Shanghai Jiao Tong University School of Medicine | Phase 4 |
See all SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
US Patents and Regulatory Information for SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ivax Pharms | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087004-002 | May 24, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vangard | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087655-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Purepac Pharm | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 088054-001 | Aug 18, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 085974-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lederle | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087511-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |